Legal Representation
Attorney
Cindy M. Zelson
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description |
|---|---|---|---|
| Jan 26, 2009 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Jan 26, 2009 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Nov 23, 2008 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Nov 11, 2008 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jun 12, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 12, 2008 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jun 12, 2008 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Dec 5, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 5, 2007 | EXT1 | S | SOU EXTENSION 1 FILED |
| Dec 5, 2007 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jun 26, 2007 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 3, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 14, 2007 | NPUB | O | NOTICE OF PUBLICATION |
| Feb 15, 2007 | ALIE | A | ASSIGNED TO LIE |
| Feb 15, 2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Jan 11, 2007 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jan 10, 2007 | CNEA | O | EXAMINERS AMENDMENT MAILED |
| Jan 9, 2007 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jan 9, 2007 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Dec 8, 2006 | CPRA | R | PRIORITY ACTION WRITTEN |
| Dec 8, 2006 | CPRA | F | PRIORITY ACTION MAILED |
| Dec 6, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 3, 2006 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of sleep diseases and disorders, gynecological diseases and disorders, cholesterol related diseases and disorders, cardiovascular diseases, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological disorders, viral disorders, and fungal disorders; pharmaceutical preparations, namely, smoking cessation preparations, dermatological preparations, preparations for the prevention and treatment of osteoporosis, and ophthalmological preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005